EMBL Ventures is an independent venture capital investor that manages two Funds with a total of €68 million capital on behalf of major European institutional and private investors. EMBL Ventures' close relationship with the European Molecular Biology Laboratory (EMBL) and its technology transfer organization EMBL Enterprise Management Technology Transfer GmbH (EMBLEM) allows it to finance disruptive technologies in an entrepreneurial start-up environment, aiming ultimately for a transaction with a partner that is seeking to acquire external product innovation. EMBL Ventures is exclusively focused on life-science investments.

"Stefan Herr was instrumental not only throughout the creation and founding of Cenix, from the very first conceptual discussions to the launch of the new legal corporate entity back in 1999, but importantly also in the conclusion of both of our subsequent VC investment rounds. The path of a first-time Biotech entrepreneur is a very challenging one for anyone to take, but would have been literally impossible for me without Stefan's support, guidance and mentoring as the company's business co-founder. This served me well, as I continue learning every day, now, in the 10th year of Cenix."
Chris Echeverri, Ph.D.; CEO/CSO, lead scientific founder of Cenix BioScience, Dresden